Business
After an intense and acrimonious months long battle for a hostile takeover of Allergan, Bill Ackman, who owns a 9.7% stake in the company,...
Hi, what are you looking for?
After an intense and acrimonious months long battle for a hostile takeover of Allergan, Bill Ackman, who owns a 9.7% stake in the company,...
On CNBC’s Mad Dash segment, Jim Cramer discussed “one of my favorite stocks, ” Zoetis, an animal health drug company spun off by Pfizer....
– Activist investor William “Bill” Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and...
– Botox maker Allergan Inc on Monday accepted a $66 billion takeover bid from Actavis Plc, ending a seven-month hostile pursuit by activist investor...
On CNBC’s Mad Dash, Jim Cramer discussed Zoetis, an animal health biotech, that is a “gem of a company” spun off by Pfizer....
Salix Pharmaceuticals was considered as a potential buy by Allergan to ward off a hostile takeover by Valeant Pharmaceuticals and activist investor Bill Ackman....
– While federal judge David Carter said Allergan had raised ” serious questions” about the legal implication of Bill Ackman’s Pershing Square and...
In the ongoing hostile pursuit to take over Allergan, major shareholder in the company, Bill Ackman and Valeant just don’t seem ready to quit,...
– With the hostile takeover saga of Botox-maker Allergan raging on for months, the situation has become even more complicated, with Actavis jumping...
Bill Ackman, manager of Pershing Square, raised $3 billion prior to Pershing Square’s debut on Amsterdam Euronext, scheduled for October 13. The fund will...